AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 22025997 — intervention group
Group type: COMPARATOR
Intervention: OFD (control)
Number of subjects: 30
Study 18287817 — intervention group
Group type: EXPERIMENTAL
Intervention: High-rolling-resistance (RR) training method
Number of subjects: 48
Study 18287817 — intervention group
Group type: COMPARATOR
Intervention: Conventional training method
Number of subjects: 48
Study 16469442 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (CIT) 40 mg
Number of subjects: 18
Study 16469442 — intervention group
Group type: EXPERIMENTAL
Intervention: Melatonin (MT) 1 mg
Number of subjects: 18
Study 16469442 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 12680886 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone propionate (FP) 1000 microg day‐1 for 7 days
Number of subjects: 10
Study 12680886 — intervention group
Group type: COMPARATOR
Intervention: Intravenous fluticasone propionate 1000 microg
Number of subjects: 10
Study 10846595 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-guided treatment
Number of subjects: 108
Study 10846595 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (control arm)
Number of subjects: 108
Study 9106575 — intervention group
Group type: EXPERIMENTAL
Intervention: Pari LC nebulizer system (300 mg tobramycin in 5 mL of 1/4 normal saline)
Number of subjects: 68
Study 9106575 — intervention group
Group type: EXPERIMENTAL
Intervention: Sidestream nebulizer system (300 mg tobramycin in 5 mL of 1/4 normal saline)
Number of subjects: 68
Study 9106575 — intervention group
Group type: EXPERIMENTAL
Intervention: UltraNeb 99/100 nebulizer system (600 mg tobramycin in 30 mL of 1/2 normal saline)
Number of subjects: 68
Study 8229026 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone
Number of subjects: 41
Study 8229026 — intervention group
Group type: EXPERIMENTAL
Intervention: Azathioprine
Number of subjects: 41
Study 8229026 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of prednisone and azathioprine
Number of subjects: 41
Study 31104856 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg of levo-pantoprazole
Number of subjects: 30
Study 31104856 — intervention group
Group type: COMPARATOR
Intervention: 40 mg of racemic pantoprazole
Number of subjects: 30
Study 30824296 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA screening
Number of subjects: 182160
Study 27401537 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP awareness
Number of subjects: 759
Study 27401537 — intervention group
Group type: EXPERIMENTAL
Intervention: PrEP use
Number of subjects: 759
Study 27401537 — intervention group
Group type: EXPERIMENTAL
Intervention: Condomless anal sex partners (PrEP-users)
Number of subjects: 759
Study 27401537 — intervention group
Group type: EXPERIMENTAL
Intervention: Condomless anal sex acts (PrEP-users)
Number of subjects: 759
Study 25731180 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief motivational intervention for substance misuse
Number of subjects: 0
Study 25731180 — intervention group
Group type: COMPARATOR
Intervention: Not applicable (control group)
Number of subjects: 0
Study 25731180 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable (intervention effect)
Number of subjects: 0
Study 24315475 — intervention group
Group type: EXPERIMENTAL
Intervention: 80-kV tube voltage
Number of subjects: 120
Study 24315475 — intervention group
Group type: COMPARATOR
Intervention: 120-kV tube voltage
Number of subjects: 120
Study 22339386 — intervention group
Group type: EXPERIMENTAL
Intervention: RelyX Unicem
Number of subjects: 66
Study 22339386 — intervention group
Group type: EXPERIMENTAL
Intervention: Panavia F 2.0
Number of subjects: 66
Study 22339386 — intervention group
Group type: EXPERIMENTAL
Intervention: Variolink II
Number of subjects: 66
Study 22339386 — intervention group
Group type: COMPARATOR
Intervention: Control (saline solution storage)
Number of subjects: 66
Study 20146701 — intervention group
Group type: EXPERIMENTAL
Intervention: Rimonabant 20 mg/day
Number of subjects: 12
Study 20146701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 17564853 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAT program (computerized progressive attentional training)
Number of subjects: 36
Study 17564853 — intervention group
Group type: COMPARATOR
Intervention: Control group (computer games)
Number of subjects: 36
Study 16359283 — intervention group
Group type: EXPERIMENTAL
Intervention: Full antibradycardia pacemaker system implantation
Number of subjects: 40
Study 16359283 — intervention group
Group type: COMPARATOR
Intervention: Full antibradycardia pacemaker system implantation and generator only implantation
Number of subjects: 40
Study 12011824 — intervention group
Group type: EXPERIMENTAL
Intervention: Epinephrine
Number of subjects: 22
Study 12011824 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine and Norepinephrine
Number of subjects: 22
Study 9469347 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate 90 mg intravenously administered as a 4-hour infusion monthly for 21 cycles
Number of subjects: 392
Study 9469347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study 9469347 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamidronate (stratum 2 patients)
Number of subjects: 392
Study 9469347 — intervention group
Group type: COMPARATOR
Intervention: Placebo (stratum 2 patients)
Number of subjects: 392
Study 8585642 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin ointment alone
Number of subjects: 52
Study 8585642 — intervention group
Group type: EXPERIMENTAL
Intervention: Mupirocin ointment plus chlorhexidine baths
Number of subjects: 52
Study 2096108 — intervention group
Group type: EXPERIMENTAL
Intervention: Heptaminol (626 mg dose)
Number of subjects: 19
Study 2096108 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 582541 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 mg of pimozide
Number of subjects: 2
Study 582541 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg of pimozide
Number of subjects: 2
Study 582541 — intervention group
Group type: COMPARATOR
Intervention: Both groups (3 mg and 8 mg)
Number of subjects: 2
Study 30136042 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice-plus-exposure regimen
Number of subjects: 0
Study 30136042 — intervention group
Group type: COMPARATOR
Intervention: Practice regimen
Number of subjects: 0
Study 30136042 — intervention group
Group type: COMPARATOR
Intervention: Exposure regimen
Number of subjects: 0
Study 30136042 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttest performance
Number of subjects: 0
Study 30136042 — intervention group
Group type: EXPERIMENTAL
Intervention: Naïve comparison performance
Number of subjects: 0
Study 29967221 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit + MapTrek group
Number of subjects: 146
Study 29967221 — intervention group
Group type: COMPARATOR
Intervention: Fitbit-only group
Number of subjects: 146
Study 26711509 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ chemoprophylaxis vaccine (CVac) - 3× monthly immunizations with 7.5 × 10(4) PfSPZ
Number of subjects: 65
Study 26711509 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 65
Study 26711509 — intervention group
Group type: EXPERIMENTAL
Intervention: PfSPZ chemoprophylaxis vaccine (CVac)
Number of subjects: 65
Study 24174392 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention (ILI)
Number of subjects: 5018
Study 24174392 — intervention group
Group type: COMPARATOR
Intervention: Diabetes support and education (DSE)
Number of subjects: 5018
Study 22718043 — intervention group
Group type: EXPERIMENTAL
Intervention: Location-targeted AdWords intervention
Number of subjects: 3752
Study 22718043 — intervention group
Group type: EXPERIMENTAL
Intervention: User-stated postcode assessment
Number of subjects: 3752
Study 22718043 — intervention group
Group type: EXPERIMENTAL
Intervention: Google AdWords targeting accuracy
Number of subjects: 3752
Study 19196113 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) - 12 J (4 J/cm²) applied intraorally and extraorally immediately after surgery
Number of subjects: 32
Study 19196113 — intervention group
Group type: COMPARATOR
Intervention: Placebo - handpiece applied without laser activation
Number of subjects: 32
Study 17093916 — intervention group
Group type: EXPERIMENTAL
Intervention: Tropisetron plus metopimazine
Number of subjects: 82
Study 17093916 — intervention group
Group type: COMPARATOR
Intervention: Tropisetron plus placebo
Number of subjects: 82
Study 15207420 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program (combination of aerobic/endurance activities, strength training, balance, and flexibility training)
Number of subjects: 0
Study 15207420 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise program
Number of subjects: 0
Study 11394594 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior cruciate ligament reconstruction
Number of subjects: 15
Study 11394594 — intervention group
Group type: COMPARATOR
Intervention: Control knees (normal knees)
Number of subjects: 15
Study 9473535 — intervention group
Group type: EXPERIMENTAL
Intervention: MTBE vapor exposure at 5, 25, and 50 ppm for 2 hours during light physical exercise.
Number of subjects: 10
Study 7734470 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine 150 mg/day
Number of subjects: 183
Study 7734470 — intervention group
Group type: COMPARATOR
Intervention: Imipramine 10 mg/day (control)
Number of subjects: 183
Study 2687898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 20 mg/kg/day
Number of subjects: 31
Study 2687898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil 40 mg/kg/day
Number of subjects: 31
Study 2687898 — intervention group
Group type: COMPARATOR
Intervention: Cefaclor 30 mg/kg/day
Number of subjects: 31
Study 2687898 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefetamet pivoxil (both doses)
Number of subjects: 31
Study 31694642 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention delivered by telephone following a six-topic protocol
Number of subjects: 443
Study 31694642 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient Navigation (PN) intervention
Number of subjects: 443
Study 27797396 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline 40 mg
Number of subjects: 80
Study 27797396 — intervention group
Group type: COMPARATOR
Intervention: Minocycline 100 mg
Number of subjects: 80
Study 25280132 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-bearing (MB) total knee arthroplasty
Number of subjects: 50
Study 25280132 — intervention group
Group type: COMPARATOR
Intervention: Fixed-bearing (FB) total knee arthroplasty
Number of subjects: 50
Study 25280132 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (FB and MB)
Number of subjects: 50
Study 24368488 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine dermis
Number of subjects: 81
Study 24368488 — intervention group
Group type: EXPERIMENTAL
Intervention: Polypropylene mesh
Number of subjects: 81
Study 24368488 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall cohort
Number of subjects: 81
Study 22646698 — intervention group
Group type: EXPERIMENTAL
Intervention: BAF312
Number of subjects: 48
Study 18848939 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance peginterferon for 3.5 years
Number of subjects: 1005
Study 18848939 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control)
Number of subjects: 1005
Study 18848939 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with cirrhosis
Number of subjects: 1005
Study 18848939 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with bridging fibrosis
Number of subjects: 1005
Study 18848939 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with serial biopsy specimens showing only fibrosis
Number of subjects: 1005
Study 17943443 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone therapy
Number of subjects: 0
Study 17943443 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat dietary pattern
Number of subjects: 0
Study 16385102 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination analgesic therapy; specific drugs and dosages not available.
Number of subjects: 0
Study 16385102 — intervention group
Group type: COMPARATOR
Intervention: Individual component drugs; specific drugs and dosages not available.
Number of subjects: 0
Study 12626202 — intervention group
Group type: EXPERIMENTAL
Intervention: Corline Heparin Surface (CHS) with standard level of heparin
Number of subjects: 60
Study 12626202 — intervention group
Group type: EXPERIMENTAL
Intervention: Corline Heparin Surface (CHS) with high level of heparin
Number of subjects: 60
Study 12626202 — intervention group
Group type: COMPARATOR
Intervention: Uncoated oxygenators
Number of subjects: 60
Study 12626202 — intervention group
Group type: EXPERIMENTAL
Intervention: Corline Heparin Surface (CHS) with low level of heparin
Number of subjects: 60
Study 10520620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pear juice (120 mL)
Number of subjects: 14
Study 10520620 — intervention group
Group type: COMPARATOR
Intervention: White grape juice (120 mL)
Number of subjects: 14
Study 7863649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered bed bath
Number of subjects: 30
Study 7863649 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive range-of-motion exercises
Number of subjects: 30
Study 7863649 — intervention group
Group type: EXPERIMENTAL
Intervention: Turning from side to side
Number of subjects: 30
Study 7863649 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-administered interventions (overall)
Number of subjects: 30
Study 7863649 — intervention group
Group type: COMPARATOR
Intervention: Order of interventions
Number of subjects: 30
Study 1937599 — intervention group
Group type: EXPERIMENTAL
Intervention: Kshaarasootra (Ayurvedic medicated thread)
Number of subjects: 502
Study 1937599 — intervention group
Group type: COMPARATOR
Intervention: Conventional surgery
Number of subjects: 502
Study 7075123 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (35 to 80 mg)
Number of subjects: 13
Study 7075123 — intervention group
Group type: EXPERIMENTAL
Intervention: Methadone (10 and 20 mg/day)
Number of subjects: 13
Study 7075123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 31911516 — intervention group
Group type: EXPERIMENTAL
Intervention: mHealth based and three‐tiered diabetes management system
Number of subjects: 19008
Study 31911516 — intervention group
Group type: COMPARATOR
Intervention: Usual care as EPHS packaged
Number of subjects: 19008
Study 31771598 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplement containing caffeine, theanine and tyrosine (SUP)
Number of subjects: 20
Study 31771598 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 20
Study 29229808 — intervention group
Group type: EXPERIMENTAL
Intervention: LLINs + IRS with deltamethrin
Number of subjects: 0
Study 29229808 — intervention group
Group type: EXPERIMENTAL
Intervention: LLINs + IRS with bendiocarb
Number of subjects: 0
Study 29229808 — intervention group
Group type: COMPARATOR
Intervention: LLINs alone
Number of subjects: 0
Study 26228414 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose antidepressant therapy
Number of subjects: 333
Study 26228414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 333
Study 26228414 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose antidepressant therapy
Number of subjects: 333
Study 26228414 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses (high, low, placebo)
Number of subjects: 333
Study 23357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive diagnostic strategy (analyses of blood cell count and C-reactive protein)
Number of subjects: 302
Study 23357491 — intervention group
Group type: COMPARATOR
Intervention: Strategy of exclusion (analyses of blood, stool samples for intestinal parasites, and sigmoidoscopies with biopsies)
Number of subjects: 302
Study 23357491 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive diagnostic strategy
Number of subjects: 302
Study 23357491 — intervention group
Group type: COMPARATOR
Intervention: Strategy of exclusion
Number of subjects: 302
Study 20718623 — intervention group
Group type: EXPERIMENTAL
Intervention: Yoga (30-minute session)
Number of subjects: 40
Study 20718623 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise (20-minute session on a bicycle ergometer)
Number of subjects: 40
Study 20718623 — intervention group
Group type: COMPARATOR
Intervention: No exercise control condition
Number of subjects: 40
Study 19524832 — intervention group
Group type: EXPERIMENTAL
Intervention: Hawley retainer
Number of subjects: 50
Study 19524832 — intervention group
Group type: COMPARATOR
Intervention: perfector/spring aligner retainer
Number of subjects: 50
Study 17307888 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training group (n = 19) allowed to continue Achilles tendon-loading activity (running and jumping) with a pain-monitoring model
Number of subjects: 38
Study 17307888 — intervention group
Group type: COMPARATOR
Intervention: Active rest group (n = 19) had to stop tendon-loading activities during the first 6 weeks
Number of subjects: 38
Study 15277916 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex-based formula (size 4 for women and size 5 for men)
Number of subjects: 237
Study 15277916 — intervention group
Group type: COMPARATOR
Intervention: Weight-based formula (size 3 for weight < 50 kg, size 4 for weight 50‐70 kg, and size 5 for weight > 70 kg)
Number of subjects: 237
Study 11557703 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse assessment with reinforcement of pelvic floor muscle training exercises and bladder training
Number of subjects: 747
Study 9489594 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg tamsulosin (as Omnic modified release capsules)
Number of subjects: 2
Study 9489594 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg terazosin (as Flotrin tablets)
Number of subjects: 2
Study 7523546 — intervention group
Group type: EXPERIMENTAL
Intervention: CYFRA 21-1
Number of subjects: 629
Study 7523546 — intervention group
Group type: EXPERIMENTAL
Intervention: CYFRA 21-1 + TPA
Number of subjects: 629
Study 7523546 — intervention group
Group type: EXPERIMENTAL
Intervention: CYFRA 21-1 + NSE
Number of subjects: 629
Study 7523546 — intervention group
Group type: COMPARATOR
Intervention: NSE
Number of subjects: 629
Study 3254832 — intervention group
Group type: EXPERIMENTAL
Intervention: AWD 26‐06 (50 mg and above)
Number of subjects: 11
Study 3254832 — intervention group
Group type: EXPERIMENTAL
Intervention: AWD 26‐06 (100 mg and 150 mg)
Number of subjects: 11
Study 3254832 — intervention group
Group type: EXPERIMENTAL
Intervention: AWD 26‐06 (150 mg)
Number of subjects: 11
Study 3254832 — intervention group
Group type: COMPARATOR
Intervention: AWD 26‐06 (25 mg)
Number of subjects: 11
Study 3254832 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 29298868 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal auditory-somatosensory stimulation for 28 days
Number of subjects: 20
Study 29298868 — intervention group
Group type: EXPERIMENTAL
Intervention: Bimodal auditory-somatosensory stimulation for 20 minutes per day for 25 days
Number of subjects: 20
Study 29298868 — intervention group
Group type: COMPARATOR
Intervention: Unimodal auditory stimulation
Number of subjects: 20
Study 28323763 — intervention group
Group type: EXPERIMENTAL
Intervention: Reamer-Irrigator-Aspirator (RIA)
Number of subjects: 22
Study 28323763 — intervention group
Group type: COMPARATOR
Intervention: Standard Reaming (SR)
Number of subjects: 22
Study 26691357 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional triamcinolone acetonide (10 mg/ml)
Number of subjects: 226
Study 26691357 — intervention group
Group type: COMPARATOR
Intervention: Topical betamethasone valearate cream 0.1% twice daily
Number of subjects: 226
Study 23434331 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpreserved timolol 0.1% gel
Number of subjects: 0
Study 23434331 — intervention group
Group type: COMPARATOR
Intervention: Preserved latanoprost 0.005%
Number of subjects: 0
Study 22036927 — intervention group
Group type: EXPERIMENTAL
Intervention: Video link for telemedicine consultations
Number of subjects: 60
Study 22036927 — intervention group
Group type: COMPARATOR
Intervention: Telephone call with viewing of digital X-ray images (PACS)
Number of subjects: 60
Study 19470803 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined resistance and aerobic training (BRE group)
Number of subjects: 24
Study 19470803 — intervention group
Group type: EXPERIMENTAL
Intervention: Protein supplementation (BRN group)
Number of subjects: 24
Study 19470803 — intervention group
Group type: COMPARATOR
Intervention: Bed rest control (BRC group)
Number of subjects: 24
Study 16713059 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose administration
Number of subjects: 0
Study 16713059 — intervention group
Group type: COMPARATOR
Intervention: Aspartame control
Number of subjects: 0
Study 15259840 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine plus cognitive-behavioural therapy (CBT+meds)
Number of subjects: 132
Study 15259840 — intervention group
Group type: COMPARATOR
Intervention: Fluoxetine (meds only)
Number of subjects: 132
Study 15259840 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (CBT+meds and meds only)
Number of subjects: 132
Study 11720060 — intervention group
Group type: EXPERIMENTAL
Intervention: Stanford Heart Attack Staying Free (SF) programme
Number of subjects: 198
Study 11720060 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) programme
Number of subjects: 198
Study 14655830 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 g L-tryptophan
Number of subjects: 20
Study 14655830 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g L-tryptophan
Number of subjects: 20
Study 14655830 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 g L-tryptophan
Number of subjects: 20
Study 14655830 — intervention group
Group type: COMPARATOR
Intervention: Lactose placebo
Number of subjects: 20
Study 7951084 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms per day)
Number of subjects: 20
Study 7951084 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms per day) + Beclocort (1 mg per day)
Number of subjects: 20
Study 7951084 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol (400 micrograms per day) + Nedocromil (Tilade 8 mg per day)
Number of subjects: 20
Study 7951084 — intervention group
Group type: EXPERIMENTAL
Intervention: Salbutamol alone or in combination with an anti-inflammatory agent
Number of subjects: 20